Immune Activation, Proinflammatory Cytokines, and Conventional Risks for Cardiovascular Disease in HIV Patients: A Case-Control Study in Bahia, Brazil

Cardiovascular events (CVE) are an increasing cause of morbi-mortality for HIV patients. The antiretroviral therapy (ART), persistent immune activation, and life style are factors that can increase CVE for such patients. We performed a case-control study to evaluate the role of coinfections and immu...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 9; p. 1469
Main Authors Brites-Alves, Clara, Luz, Estela, Netto, Eduardo M, Ferreira, Thalis, Diaz, Ricardo Sohbie, Pedroso, Celia, Page, Kimberly, Brites, Carlos
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 26.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cardiovascular events (CVE) are an increasing cause of morbi-mortality for HIV patients. The antiretroviral therapy (ART), persistent immune activation, and life style are factors that can increase CVE for such patients. We performed a case-control study to evaluate the role of coinfections and immune markers associated with CVE. We included patients under ART, with undetectable plasma viral load ≥12 months. Patients presenting any condition of risk for CVE were considered cases, and those without CVE risk conditions were controls. History of viral infections (Epstein-Barr virus, hepatitis C virus, hepatitis B virus, and cytomegalovirus), exposure to antiretroviral drugs, time since HIV diagnosis/under ART, and life style (demographics, weight, smoking, alcohol, and illicit drug use) were assessed. CD4/CD8 nadir and current counts, nadir and current CD4/CD8 ratio, immune activation markers (CD4CD38HLADR, CD8CD38HLADR), and serum levels of eight cytokines [IL-2, IL-4, IL-6, IL-10, tumoral necrosis factor-alpha (TNF-α), interferon gamma, macrophage inflammatory proteins 1 alpha, and interferon-inducing protein (IP-10)] were measured. Two-thirds of patients were males. Cases (  = 106) were older (52.8 vs 49.5 years,  = 0.002), had higher levels of creatinine (0.97 vs 0.87 mg/dL,  = 0.002) and IL-6 (0.67 vs 0.52 pg/mL,  = 0.04) than controls (  = 114). There was no difference between groups regarding frequency of CD4CD39HLADR+ or CD8CD38HLADR+ cells. We found a significant correlation (all patients) between increased frequency of CD4CD38HLADR+ cells and levels of IP-10 (  = 0.171,  = 0.02) and TNF-α (  = 0.187,  = 0.01). Levels of IL-6 (  = 0.235,  = 0.02), TNF-α (  = 0.267,  = 0.01), and IP-10 (  = 0.205,  = 0.04) were correlated with CD4CD38HLADR+ cells, in controls. Higher frequency of CD4CD38HLADR+ cells was also correlated with levels of IP-10 (  = 0.271,  = 0.04) in patients presenting with arterial hypertension. Frequency of CD4CD38HLADR+ cells was negatively correlated with levels of IL-2 (  = -0.639,  = 0.01) and IL-6 (  = -0.0561,  = 0.03) in patients with hypercholesterolemia. No association was detected between viral infections or smoking/alcohol use and immune activation markers. Our results indicate IL-6 levels are associated with increased CV risk. Activated CD4+ T cells were associated with increased levels of proinflammatory cytokines.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Specialty section: This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology
Reviewed by: Felipe Bonfim Freitas, Instituto Evandro Chagas, Brazil; Anthony Jaworowski, RMIT University, Australia
Edited by: Antonio C. R. Vallinoto, Institute of Biological Sciences (ICB) of Federal University of Pará, Brazil
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2018.01469